PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo (Q39493165)

12 September 2017

title

PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo (English)

1 reference

12 September 2017

1 reference

A. P. Cumming

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21826098

9 December 2024

S. N. Hopmans

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21826098

9 December 2024

S. Vukmirović-Popović

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21826098

9 December 2024

W. C. Duivenvoorden

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21826098

9 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21826098

9 December 2024

publication date

9 August 2011

1 reference

full work available at URL

12 September 2017

https://www.nature.com/articles/pcan201134.pdf

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

https://www.nature.com/articles/pcan201134

9 December 2024

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Prostate Cancer and Prostatic Diseases

9 December 2024

published in

1 reference

12 September 2017

volume

14

1 reference

12 September 2017

issue

4

1 reference

12 September 2017

page(s)

286-294

1 reference

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2 ), a tight-binding inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Use and Assessment of PSA in Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Activation of the Zymogen Form of Prostate-Specific Antigen by Human Glandular Kallikrein 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Characterization of hK4 (prostase), a prostate-specific serine protease: activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Seminal plasma contains "BPSA," a molecular form of prostate-specific antigen that is associated with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

A comprehensive nomenclature for serine proteases with homology to tissue kallikreins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Evidence that the prostate-specific antigen (PSA)/Zn2 axis may play a role in human prostate cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Ligation of prostate cancer cell surface GRP78 activates a proproliferative and antiapoptotic feedback loop: a role for secreted prostate-specific antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Prostate-specific antigen modulates genes involved in bone remodeling and induces osteoblast differentiation of human osteosarcoma cell line SaOS-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Mechanisms of bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Pro PSA: a more cancer specific form of prostate specific antigen for the early detection of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

LNCaP produces both putative zymogen and inactive, free form of prostate-specific antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Skeletal metastasis of prostate adenocarcinoma in rats: Morphometric analysis and role of parathyroid hormone-related protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

Generalised increase in bone resorption in carcinoma of the prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/PCAN.2011.34

31 March 2020

Identifiers

DOI

10.1038/PCAN.2011.34

1 reference

12 September 2017

1 reference